Search Results

Effectiveness and Tolerability of Dual Therapy with Dolutegravir Plus Darunavir/ cobicistat in Treatment-Experienced Patients with HIV: A 144-Week Follow-Up.

• Authors : Shin-Woo Kim; Hyun Wook Jang; Hyun-Ha Chang

Subjects: NUCLEOSIDE reverse transcriptase inhibitors; DRUG side effects; DOLUTEGRAVIR

• Source: Infection & Chemotherapy; Jun2024, Vol. 56 Issue 2, p247-255, 9p

Record details

Dyslipidaemia after switch to tenofovir alafenamide (TAF)‐based cART regimens in a cohort of HIV‐positive patients: what clinical relevance?

• Authors : Gazzola, L; Tagliaferri, G; De Bona, A

Subjects: CARDIOVASCULAR diseases risk factors; COMBINATION drug therapy; CONFIDENCE intervals

• Source: HIV Medicine. Feb2021, Vol. 22 Issue 2, p140-145. 6p.

Record details

Ritonavir- or cobicistat-boosted antiretroviral therapy and direct oral anticoagulants: A case for apixaban.

• Authors : Nisly, Sarah A; Stevens, Brooke N

• Source: International Journal of STD & AIDS; Jun2019, Vol. 30 Issue 7, p718-722, 5p, 2 Charts

Record details

Sustained HIV virologic suppression with crushed combination tablets containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide.

• Authors : Kaplun, Olga¹; Psevdos, George²

Subjects: *HIV prevention; *THIAZOLES; *COMBINATION drug therapy

• Source: American Journal of Health-System Pharmacy. Aug2019, Vol. 76 Issue 16, p1180-1181. 2p.

Record details

Simplification of ART in a patient living with multidrug resistant HIV-1: A case report using twice daily cobicistat and darunavir.

• Authors : Brizzi, Marisa B; Novak, Richard M; Chiampas, Thomas D

Subjects: HIV; ANTIRETROVIRAL agents; HIV-positive persons

• Source: International Journal of STD & AIDS; Nov2019, Vol. 30 Issue 13, p1333-1336, 4p, 1 Chart

Record details

Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims.

• Authors : Malinverni, Stefano; Bédoret, Floriane; Bartiaux, Magali

• Source: Sexually Transmitted Infections; Aug2021, Vol. 97 Issue 5, p329-333, 9p

Record details

Chemsex and antiretroviral prescribing in an HIV cohort in Brighton, UK.

• Authors : Adler, Zoe¹; Fitzpatrick, Colin¹; Broadwell, Nicholas²

Subjects: *HETEROCYCLIC compounds; *CROSS-sectional method; *ANTIRETROVIRAL agents

• Source: HIV Medicine. Aug2022, Vol. 23 Issue 7, p797-800. 4p.

Record details

Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in China.

• Authors : Sun, Liqin (AUTHOR); He, Yun (AUTHOR); Xu, Liumei (AUTHOR)

• Source: JAIDS: Journal of Acquired Immune Deficiency Syndromes. Oct2022Supplement, Vol. 91, pS8-S15. 8p.

Record details

Effect of monotherapy with darunavir/cobicistat on viral load and semen quality of HIV-1 patients.

• Authors : López-Ruz, Miguel A.; López-Zúñiga, Miguel A.; Gonzalvo, María Carmen

Subjects: HIV-positive persons; HIV infections; THERAPEUTICS

• Source: PLoS ONE; 4/24/2018, Vol. 13 Issue 4, p1-9, 9p

Record details

Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method.

• Authors : Midde, Narasimha M.; Rahman, Mohammad A.; Rathi, Chetan

Subjects: THERAPEUTICS; HIV infections; ETHANOL

• Source: PLoS ONE; 2/12/2016, Vol. 11 Issue 2, p1-19, 19p

Record details